T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
T2 Biosystems, Inc. (TTOO)
Last t2 biosystems, inc. earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.t2biosystems.com/phoenix.zhtml?c=253528&p=irol-faq
Company Research
Source: GlobeNewswire
LEXINGTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted a recently published article in The Lancet, a world-leading medical journal. The article titled “Changing the Culture of Blood Culture” was authored by Sally Davies, Richard A Marfuggi, Rick A Bright, Steve Brozak, and Michael Osterholm on September 20, 2024. “The T2 Biosystems team is commercializing the only FDA-cleared direct-from-blood diagnostics able to rapidly detect bacterial and fungal pathogens, and we applaud the authors for raising awareness of the limitations of blood culture,” stated John Sperzel, Chairman and CEO of T2 Biosystems. “As noted by the authors, rapid culture-independent diagnostics have the potential to improve health outcomes and strengthen the global response to infectious diseases, and T2 Biosystems is working to leverage our technology to
Show less
Read more
Impact Snapshot
Event Time:
TTOO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TTOO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TTOO alerts
High impacting T2 Biosystems, Inc. news events
Weekly update
A roundup of the hottest topics
TTOO
News
- T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European UnionGlobeNewswire
- T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric PatientsGlobeNewswire
- T2 Biosystems Provides Updates on its New Product Development Pipeline ProgressGlobeNewswire
- T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswire
- T2 Biosystems to Attend Upcoming Investor ConferencesGlobeNewswire
TTOO
Analyst Actions
- 7/30/24 - Canaccord Genuity
TTOO
Sec Filings
- 9/20/24 - Form 8-K
- 9/17/24 - Form 4
- 9/16/24 - Form 8-K
- TTOO's page on the SEC website